Afya (AFYA) to Release Quarterly Earnings on Thursday

Afya (NASDAQ:AFYA) is projected to announce its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of $0.36 per share and revenue of $174.7420 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, March 12, 2026 at 5:00 PM ET.

Afya Stock Up 2.1%

Shares of AFYA opened at $13.44 on Thursday. The stock’s 50-day moving average price is $14.57 and its two-hundred day moving average price is $14.82. Afya has a 12 month low of $13.00 and a 12 month high of $19.90. The company has a market capitalization of $1.26 billion, a PE ratio of 9.67, a PEG ratio of 0.64 and a beta of 0.52. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on AFYA shares. Sanford C. Bernstein raised Afya to a “market perform” rating in a research note on Friday, January 16th. Wall Street Zen lowered shares of Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 31st. Bank of America downgraded shares of Afya from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $22.00 to $17.00 in a research report on Tuesday, February 24th. UBS Group reiterated a “neutral” rating and set a $16.00 price objective (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $17.30.

Hedge Funds Weigh In On Afya

Institutional investors and hedge funds have recently modified their holdings of the business. Van ECK Associates Corp lifted its stake in shares of Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after buying an additional 1,377 shares in the last quarter. Daiwa Securities Group Inc. acquired a new stake in shares of Afya in the 4th quarter worth about $43,000. Arrowstreet Capital Limited Partnership lifted its position in Afya by 5.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after acquiring an additional 3,626 shares in the last quarter. Militia Capital Partners LP acquired a new position in Afya during the 2nd quarter valued at about $71,000. Finally, Quantbot Technologies LP bought a new stake in Afya during the 2nd quarter worth approximately $117,000. 88.02% of the stock is currently owned by institutional investors.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.